• Ownership

Matthew Ros - Insider Trading & Ownership

Entity
Individual
Location
C/O Epizyme, Inc., 400 Technology Square, Cambridge, MA
Summary
The estimated net worth of Matthew Ros is at least $905K dollars as of April 3, 2025. Matthew Ros is the Chief Operating Officer of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $352K. Matthew Ros is the Director of Cogent Biosciences, Inc. and owns shares of Cogent Biosciences, Inc. (COGT) stock worth about $321K. Matthew Ros is the Executive Vice President, Chief Strategy & Business Officer of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $232K.
All Insider Reports
All Insider Reports

Ownership of Matthew Ros

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VSTM Verastem, Inc. Chief Operating Officer $352K Apr 1, 2025
COGT Cogent Biosciences, Inc. Director $321K Jun 5, 2024
EPZM Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer $232K Aug 16, 2021

Insider Transactions Reported by Matthew Ros:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.